Orgenesis Inc.
Datakwaliteit: 100%
ORGS
UNKNOWN
Manufacturing
Chemicals
€ 0,60
▲
€ 0,02
(3,45%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-39,36%
Groei
Revenue Growth (5Y)
-39,36%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-97,02%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net Margin-4653,62%
Op. Margin-3842,32%
Veiligheid
Debt / Equity
N/A
Current Ratio0,07
Interest CoverageN/A
Waardering
PE (TTM|NTM)
-0,12 | 0,26
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -39,36% annually over 5 years
Negative free cash flow of -17,34 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 57,66%
Price History
Financiële Trends
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstverassingen
EPS
Reported
Estimate
| Q42022 | Q12023 | Q22023 | Q32023 | |
|---|---|---|---|---|
| Reported | -€ 1,16 | -€ 1,49 | -€ 1,50 | -€ 4,30 |
| Estimate | € 0,00 | € 0,50 | € 0,60 | € 1,00 |
| Verrassing | 0,00% | -397,60% | -350,00% | -530,00% |
Growth
Rev 5Y: -39,36% · Earnings 1Y: N/A
Growth
Rev 5Y: -39,36% · Earnings 1Y: N/A| Revenue Growth (1Y) | -97,02% | Revenue Growth (3Y) | -83,05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -39,36% | Earnings Growth (5Y) | N/A |
Profitability
ROE: N/A · Net Margin: -4653,62%
Profitability
ROE: N/A · Net Margin: -4653,62%| Revenue (TTM) | 1,04 M | Net Income (TTM) | -48,17 M |
| ROE | N/A | ROA | -159,85% |
| Gross Margin | -86,28% | Operating Margin | -3842,32% |
| Net Margin | -4653,62% | Free Cash Flow (TTM) | -17,34 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 0,07
Safety
D/E: N/A · Current: 0,07| Debt / Equity | N/A | Current Ratio | 0,07 |
| Interest Coverage | N/A | Asset Turnover | 0,03 |
| Working Capital | -33,53 M | Tangible Book Value | -33,64 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -0,12 · EV/EBITDA: N/A
Valuation
P/E: -0,12 · EV/EBITDA: N/A| P/E Ratio | -0,12 | Forward P/E | 0,26 |
| P/B Ratio | N/A | P/S Ratio | 5,49 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | 384,62% |
| FCF Yield | -305,06% | ||
| Market Cap | 5,68 M | Enterprise Value | 10,38 M |
Per Share
EPS: 11,44 · FCF/Share: -1,77
Per Share
EPS: 11,44 · FCF/Share: -1,77| EPS (Diluted TTM) | 11,44 | Revenue / Share | 0,11 |
| FCF / Share | -1,77 | OCF / Share | -1,74 |
| EPS CAGR (1Y) | 498,95% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | 67,54% | ||
Efficiency
FCF Conv: 36,00% · CapEx/Rev: 25,41%
Efficiency
FCF Conv: 36,00% · CapEx/Rev: 25,41%| CapEx / Revenue | 25,41% | FCF Conversion | 36,00% |
| SBC-Adj. FCF | -20,05 M | Growth Momentum | -57,66 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1,04 M | 34,74 M | 36,03 M | 35,50 M | 7,65 M |
| Net Income | -48,17 M | -55,36 M | -14,89 M | -18,05 M | -1,11 M |
| EPS (Diluted) | 11,44 | 1,91 | — | — | — |
| Gross Profit | -893.000,0 | -5,73 M | — | — | — |
| Operating Income | -39,77 M | -53,64 M | -8,60 M | -16,80 M | 95,78 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 9,62 M | 10,62 M | — | 36,64 M | 83,99 M |
| SG&A Expenses | 14,82 M | 35,13 M | 15,59 M | 14,71 M | 18,97 M |
| D&A | 2,09 M | 1,56 M | 1,98 M | 1,86 M | 1,44 M |
| Interest Expense | — | — | — | — | — |
| Income Tax | 97.000,0 | 473.000,0 | 209.000,0 | 108.000,0 | 1,61 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1,35 M | 14,55 M | 90,93 M | 59,84 M | 77,68 M |
| Total Liabilities | 38,88 M | 35,54 M | 31,65 M | 21,21 M | 24,96 M |
| Shareholders' Equity | -37,50 M | -20,98 M | 27,56 M | 38,49 M | 52,58 M |
| Total Debt | 6,18 M | 650.000,0 | — | — | — |
| Cash & Equivalents | 78.000,0 | 837.000,0 | 5,31 M | 5,47 M | 44,92 M |
| Current Assets | 761.000,0 | 4,08 M | 46,32 M | 25,76 M | 50,08 M |
| Current Liabilities | 26,92 M | 16,41 M | 15,91 M | 15,37 M | 16,29 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -0,1 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -54,5 |
| Net Margin % | -4653,6 | -41,5 |
| Rev Growth 5Y % | -39,4 | 1,8 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"ORGS","listing_kind":"stock","pathname":"/stocks/orgs","exchange":"UNKNOWN","country":"US"}}